로딩 중…
StockDiggingStockDigging

SHINPOONG PHARMACEUTICAL CO.,LTD

019170· KOSPI
₩8,690-2.69%
2026-06-19

Price Chart

SHINPOONG PHARMACEUTICAL CO.,LTD-51.26%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap455.52B KRW
Revenue233.80B KRW
Net Income450.5M KRW
Total Assets371.88B KRW
Net Assets292.26B KRW
Employees832
Value
P/E1011.17x
P/B1.56x
P/S1.95x
EV/EBITDA86.80x
FCF Yield3.02%
Profitability
ROE0.15%
ROA0.12%
Op. Margin2.25%
Revenue Growth-1.59%
Financial Health
Debt Ratio27.24%
Total Debt53.81B KRW
FCF13.78B KRW
Cash52.15B KRW
Current Ratio3.20x
Net Debt/EBITDA0.32x
Dividend
Div. Growth0.00%
Performance
1Y Return-51.26%
1M Return-17.55%
From 52W High-57.61%
1Y MDD-52.61%
Trading
Volume90,132 shares
Foreign Own.5.96%
Per Share
EPS190 KRW
BPS5,507 KRW

Company Info

CEO 유 제 만
Employees 832
Founded 1986
HQ 경기도 안산시, KR

Established in 1962 and listed on the Korea Exchange in 1990, the company is a mid-sized pharmaceutical enterprise primarily focusing on the manufacturing and sale of finished pharmaceutical products and active pharmaceutical ingredients. It operates six subsidiaries for overseas market entry in countries like Vietnam, Philippines, Myanmar, and the United States. The company concentrates its mid-to-long-term capabilities on global new drug development and secures domestic market competitiveness by launching improved new drugs and first generics, and fostering highly profitable items into mega-products.